Clinical and Radiographic Assessment of Neo Putty MTA Versus Formocresol Used in Vital Pulpotomy of Mandibular Primary Molars

NCT07437794 — Not applicable, Not yet recruiting, 68 participants, October University for Modern Sciences and Arts

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Clinical and Radiographic Assessment of Neo Putty MTA Versus Formocresol Used in Vital Pulpotomy of Mandibular Primary Molars: A Randomized Clinical Trial

RegistryNCT07437794
StatusNot yet recruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, treatment
Enrollment68 (Estimated)
SponsorOctober University for Modern Sciences and Arts (Other)
ConditionsDeep Caries in Primary Molars
InterventionsNeoPutty MTA, Formocresol (Drug)
Datesstart 2026-03-01 (estimated), primary completion 2026-04-01 (estimated), completion 2026-05-01 (estimated), first posted 2026-02-27, last updated 2026-02-27
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
All trials for Deep Caries in Primary Molars All trials of NeoPutty MTA All trials of Formocresol

-Summary

This randomized clinical trial aims to evaluate the clinical and radiographic success of NeoPutty MTA compared to formocresol in vital pulpotomy of mandibular primary molars in children aged 4 to 9 years. Participants will be randomly allocated into two groups (1:1) to receive pulpotomy using either NeoPutty MTA or formocresol, followed by restoration with stainless steel crowns. Clinical and radiographic outcomes will be assessed during follow-up visits.

Expand all sections  ·  Collapse all

+Detailed description

Pulpotomy is a commonly performed vital pulp therapy in pediatric dentistry. Formocresol has been widely used due to its high clinical success; however, concerns exist regarding its potential toxicity. NeoPutty MTA is a premixed bioceramic material introduced as an alternative pulpotomy agent with improved handling properties and bioactivity. This randomized parallel-group clinical trial will compare NeoPutty MTA versus formocresol in vital pulpotomy of mandibular primary molars. Children aged 4-9 years presenting with asymptomatic carious mandibular primary molars will be recruited from the Pediatric Dentistry Department, Faculty of Dentistry, MSA University. Eligible teeth will undergo standardized pulpotomy procedures, restoration with glass ionomer cement, and stainless steel crowns. Clinical and radiographic follow-up will be performed at scheduled intervals to evaluate success and failure outcomes.

+Arms and interventions

ArmTypeInterventionsDescription
Arm A: NeoPutty MTA PulpotomyExperimentalDrug: NeoPutty MTAParticipants will receive vital pulpotomy of mandibular primary molars using NeoPutty MTA as the pulpotomy medicament, followed by restoration with glass ionomer cement and stainless steel crown.
Arm B: Formocresol PulpotomyActive comparatorDrug: FormocresolParticipants will receive vital pulpotomy of mandibular primary molars using formocresol (1:5 dilution of Buckley's formocresol) applied with cotton pellet, followed by reinforced zinc oxide eugenol, glass ionomer cement, and stainless steel crown.
  • NeoPutty MTA (Drug): NeoPutty MTA (NuSmile) will be placed directly over the radicular pulp stumps after hemostasis, then the tooth will be sealed with resin-modified glass ionomer cement and restored with stainless steel crown.
  • Formocresol (Drug): A sterile cotton pellet lightly moistened with a 1:5 dilution of Buckley's formocresol will be placed against the pulp stumps for 3-5 minutes, then removed. Reinforced zinc oxide eugenol will be placed, followed by glass ionomer cement and stainless steel crown restoration.

+Outcome measures

Primary outcomes

  • Postoperative pain [1 week postoperatively, 3 months, 6 months, 9 months and 12 months]: Presence or absence of spontaneous postoperative pain reported by the child/parent after pulpotomy treatment.

Secondary outcomes

  • Pain on percussion [3 months, 6 months, 9 months and 12 months]: Description: Presence or absence of pain on percussion during clinical follow-up visits.
  • Presence of sinus tract, fistula or abscess [3 months, 6 months, 9 months and 12 months]: Description: Clinical evaluation for presence of swelling, abscess, or sinus/fistulous tract related to the treated tooth.
  • Tooth mobility [3 months, 6 months, 9 months and 12 months]: Description: Tooth mobility assessed clinically using a mobility scoring system ranges from 0-3 were (score 0 the best) indicates no mobility and (score 3 the worst) indicates vertical and horizontal mobility.
  • Widening of Periodontal Ligament Space [6 months and 12 months after treatment]: Radiographic evidence of widening of the periodontal ligament space assessed using standardized periapical radiographs. Recorded as Present / Absent.
  • Internal and External Root Resorption [6 months and 12 months after treatment]: Radiographic evidence of internal or external root resorption observed on periapical radiographs. Recorded as Present / Absent.
  • Furcal or Periapical Radiolucency [6 months and 12 months after treatment]: Presence of radiolucent lesion in the furcation or periapical area detected on standardized periapical radiographs. Recorded as Present / Absent.

+Eligibility

Sex: All, ages: 4 Years to 9 Years

Inclusion Criteria:

Children with asymptomatic decayed primary mandibular molar(s).

* Patient and parent showing cooperation and compliance.
* Children 4-9 years old.
* Vital carious primary(s) with complete root formation.
* Asymptomatic teeth or without clinical symptoms of spontaneous pain.
* No clinical evidence of pulp degeneration like the history of spontaneous or nocturnal pain, tenderness to percussion, pathologic tooth mobility, swelling, or fistulous tract.
* Both genders will be included.
* No radiographic evidence of pulp degeneration such as internal root resorption, external root resorption, or furcal radiolucency.
* Presence of two thirds of the root.
* Teeth that can be restored.
* Children with prior parental consent.

Exclusion Criteria:

* History of any systemic disease.
* Hemostasis is not achieved within 5 minutes of pulp amputation, by direct contact with a wet cotton pellet before the material placement.
* The remaining radicular tissue was non-vital (with suppuration or purulence necrosis).

+Locations (1)

FacilityCityCountryStatus
October university for modern sciences and artsGiza, Giza GovernorateEgypt